Predictive models for hERG potassium channel blockers
- 1 August 2005
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (15), 3637-3642
- https://doi.org/10.1016/j.bmcl.2005.03.062
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Validation of a [3H]Astemizole Binding Assay in HEK293 Cells Expressing HERG K+ ChannelsJournal of Pharmacological Sciences, 2004
- Understanding the Structure−Activity Relationship of the Human Ether-a-go-go-Related Gene Cardiac K+ Channel. A Model for Bad BehaviorJournal of Medicinal Chemistry, 2003
- High Throughput Ion-Channel Pharmacology: Planar-Array-Based Voltage ClampASSAY and Drug Development Technologies, 2003
- A High-Throughput HERG Potassium Channel Function Assay: An Old Assay with a New LookDrug Development and Industrial Pharmacy, 2002
- Safety of Non-Antiarrhythmic Drugs that Prolong the QT Interval or Induce Torsade de PointesDrug Safety, 2002
- Development and Evaluation of High Throughput Functional Assay Methods for hERG Potassium ChannelSLAS Discovery, 2001
- [3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screenEuropean Journal of Pharmacology, 2001
- High affinity blockade of the HERG cardiac K+ channel by the neuroleptic pimozideEuropean Journal of Pharmacology, 2000
- Cellular mechanism of aminoglycoside tolerance in long-term gentamicin treatmentAmerican Journal of Physiology-Cell Physiology, 1997
- A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channelCell, 1995